Reshape ApS: Financial statements 2024
CVR: 40056173
Source: annual report 2024, Danish Business Authority
01/04/2023 – 31/03/2024
Reshape ApS (CVR 40056173) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 1,728,927 and a net result of DKK -12,222,020 compared with DKK -4,638,554 the year before. That is a decrease of 12.2% compared with the year before. Equity in the 2024 report amounted to DKK 25,058,134. The solvency ratio was 87.5%. The company had 18 employees in the financial year.
- Gross Profit
- DKK 1,728,927
- Profit/Loss
- DKK -12,222,020
- Equity
- DKK 25,058,134
- Total Assets
- DKK 28,631,868
- Employees
- 18
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | 1.7 mio. | -12.2 mio. | 25.1 mio. | 18 |
| 2023 | - | 2 mio. | -4.6 mio. | 26.9 mio. | 10 |
| 2022 | - | -118 t. | -1.6 mio. | 5.5 mio. | 16 |
| 2021 | - | 593 t. | 52 t. | 1.3 mio. | 7 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningAbout Reshape ApS
Reshape ApS is a Danish company of the type Anpartsselskab based in København Ø, founded in 2018. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Carl-Emil Grøn Fuglesang, Daniel Storgaard and Magnus Nyborg Madsen. The company is owned by Reshape Biotech Inc.. According to the 2026 annual report, the company had an average of 56 employees. In 2026, the company reported a gross profit of DKK 5,310,622 and a net result of DKK -42,643,506 compared with DKK -35,557,856 the year before. Equity in the 2026 report amounted to DKK 75,515,117.